20. Evans, op. cit. 8. Y. Omura et al, '177 cardiovascular risk factors, classified in 10 categories. Acupuncture and Electrotherapy Research (1996) 21 (1), 21-76. 21. B. Macmahon, D. Trichopoulos, Epidemiology: Principles and methods. (Little, Brown and Co, 1996). 10. Evans, op. cit. 11. P. Duesberg (editor) AIDS: Virus or drug-induced? (Dordrecht, Kluwer Academic Publishing, 1996). 12. A. Hall, 'What is medical epidemiology' (editorial), Tropical Medicine and International Health (1996, 1 (4)), 407-8. 13. J. P. Vandenbroucke 'Is the "Causes of Cancer" a miasma theory for the end of the twentieth century?' International Journal of Epidemiology (1988) 17, 708-9. 22. N. Pearce et al. vLimitations of biomarkers of exposure in cancer epidemiology', Epidemiology (1995) 6(2) 190-94. 23. P. McKegue (1998), cyfathrebiad personol. 24. Extended Epidemiology Course Manual, 25. A. Wyke, 21st-Century Miracle Medicine. Robosurgery, Wondercures, and the Quest for Immortality (New York and London, Plenum, 1997). 26. D. Ford, D.F.Easton, J. Peto, vEstimates of the gene frequency of BRAC1 and its contribution to breast and ovarian cancer incidence', American Journal of Human Genetics (1995) 57 (6) 1475-62; J. Peto et al., 'Cancer mortality in relatives of women with breast cancer: the OPCS study'. International Journal ofCancer (1996, 65 (3)), 275-83. 27. Pearce, op. cit. 20. Wyke, op. cit. 28. C. Lerman, M.D. Shwartz ?L.H, C. Hughes, S. Narod, H.T. Lynch, 'The influence of psychological distress on use of genetic teasting for cancer risk', Journal of Consultative Clinicaì Psychology (1997) 65 (3), 414-420; H. Lynch et al, 'A descriptive study of BRCAI testing and reactions to disclosure of test results', Cancer (1997) 79 (11), 2219-2228. 29. 'The American Society of Human Genetics Board of Directors and the American College of Medical Genetics Board of Directors Report. Points to consider: Ethical and psychological implications of genetic testing in children and adolescents', American Journal of Human Genetics (1995) 57, 1233-1241. 30. J. Leiden, 'Gene therapy promises, pitfalls and prognosis', The New England Journal of Medicine (1996) 333, 871-873. 24. Ibid. 25. Wyke, op. cit.